GlucoTrack, Inc. (GCTK)
GlucoTrack, Inc.
301 Route 17 North
Suite 800
Rutherford, NJ 07070
United States
201 842 7715
https://glucotrack.com
Sector(es): Healthcare
Industria: Medical Instruments & Supplies
Empleados a tiempo completo: 6
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Paul V. Goode Ph.D. | Chief Executive Officer | 225k | N/D | 1969 |
| Mr. Mark Tapsak Ph.D. | Vice President of Technology | 165k | N/D | 1969 |
| Ms. Drinda Benjamin | Vice President of Marketing | N/D | N/D | 1976 |
| Mr. James P. Thrower Ph.D. | Vice President of Engineering | 230k | N/D | 1970 |
| Mr. Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board | 187.39k | N/D | 1954 |
| Mr. David Malka BA | Co-Founder | 191.86k | N/D | 1965 |
| Mr. James S. Cardwell | Chief Financial Officer | N/D | N/D | 1961 |
Descripción
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Gestión corporativa
La calificación ISS Governance QuickScore de GlucoTrack, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
